MedPage Today on MSN
Blood Clots in Ulcerative Colitis; AI Tool for MASH; Stomach Cancer Screening?
A liquid biopsy involving a half-dozen cell-free and exosome-based circulating biomarkers showed high specificity and ...
Blood is a rich source for biomarker development, and CTCs are increasingly proving themselves to be valuable in cancer ...
Special Report: Rhythm Biosciences surged more than 30% on Friday after confirming the commercial launch of its ColoSTAT ...
The test, a cell-free DNA test, uses a sample of the mother's blood to screen for certain conditions in the developing fetus ...
Tulane Ventures has invested $125,000 in Beken Bio, a biotech company developing early-detection blood tests for some of the ...
Rhythm Biosciences Ltd. ( ($AU:RHY) ) has issued an update. Rhythm Biosciences Ltd has initiated the commercialization of its ColoSTAT® test, a ...
Tulane Ventures invests $125K in Beken Bio to advance early cancer detection technology and expand biotech innovation in New ...
The Integrated Healthcare Association’s Align. Measure. Perform. program celebrates top-performing and most-improved providers.OAKLAND, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Integrated ...
Senate Republicans want to give Americans up to $1,500 to cover health expenses rather than extending enhanced Affordable ...
Stockhead on MSN
Closing Bell: ASX finds its groove, up 1.23pc as resources rally
4DMedical (ASX:4DX) led healthcare higher with an 8.82% bounce. 4DX has locked in $30.2 million in new funds through an ...
Paired with insomnia, anxiety appears even more detrimental to the immune system. In a Nutshell The 75% problem: ...
Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect® molecular residual disease (MRD) test in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback